Correlation Between Vitrolife and CellaVision

Can any of the company-specific risk be diversified away by investing in both Vitrolife and CellaVision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vitrolife and CellaVision into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vitrolife AB and CellaVision AB, you can compare the effects of market volatilities on Vitrolife and CellaVision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vitrolife with a short position of CellaVision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vitrolife and CellaVision.

Diversification Opportunities for Vitrolife and CellaVision

0.7

Correlation Coefficient

Vitrolife  CellaVision

Poor diversification

The 3 months correlation between Vitrolife and CellaVision is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Vitrolife AB and CellaVision AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CellaVision AB and Vitrolife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vitrolife AB are associated (or correlated) with CellaVision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CellaVision AB has no effect on the direction of Vitrolife i.e., Vitrolife and CellaVision go up and down completely randomly.

Pair Corralation between Vitrolife and CellaVision

Assuming the 90 days trading horizon Vitrolife AB is expected to generate 0.91 times more return on investment than CellaVision. However, Vitrolife AB is 1.1 times less risky than CellaVision. It trades about -0.07 of its potential returns per unit of risk. CellaVision AB is currently generating about -0.12 per unit of risk. If you would invest  25,160  in Vitrolife AB on September 3, 2024 and sell it today you would lose (2,680) from holding Vitrolife AB or give up 10.65% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Vitrolife AB  vs.  CellaVision AB

Vitrolife AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vitrolife AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

CellaVision AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CellaVision AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Vitrolife and CellaVision

The main advantage of trading using opposite Vitrolife and CellaVision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vitrolife position performs unexpectedly, CellaVision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CellaVision will offset losses from the drop in CellaVision's long position.

The idea behind Vitrolife AB and CellaVision AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.